Biohaven Ltd.
BHVN · XNYSCIK 1935979fmd_1AXR5ZGESEZVCD9VJX4S2XARAKManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2026, 24 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Research and development | 98 | 181 | 437 | 373 | 796 | 635 |
| Total operating expenses | 115 | 219 | 568 | – | – | – |
| Operating income | (115) | (219) | (568) | (436) | (885) | (745) |
| Interest and investment income | – | – | 3 | 18 | 22 | 15 |
| Other non-operating income (expense) | (4) | 6 | (2) | 27 | 39 | 8 |
| Income before taxes | (119) | (212) | (570) | (410) | (846) | (737) |
| Income tax expense | 0 | 1 | 0 | (1) | 1 | 1 |
| Net income from continuing operations | (119) | (214) | (570) | (408) | (846) | (739) |
| Net income | (119) | (214) | (570) | (408) | (846) | (739) |